Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Prevalence and predictors of probable depression in prostate cancer survivors.

Erim DO, Bensen JT, Mohler JL, Fontham ETH, Song L, Farnan L, Delacroix SE, Peters ES, Erim TN, Chen RC, Gaynes BN.

Cancer. 2019 Oct 1;125(19):3418-3427. doi: 10.1002/cncr.32338. Epub 2019 Jun 27.

PMID:
31246284
2.

Patterns and predictors of self-reported clinical diagnosis and treatment for depression in prostate cancer survivors.

Erim DO, Bensen JT, Mohler JL, Fontham ETH, Song L, Farnan L, Delacroix SE, Peters ES, Erim TN, Chen RC, Gaynes BN.

Cancer Med. 2019 Jul;8(8):3648-3658. doi: 10.1002/cam4.2239. Epub 2019 May 20.

3.

Association among plasma 1,25(OH)2 D, ratio of 1,25(OH)2 D to 25(OH)D, and prostate cancer aggressiveness.

Ramakrishnan S, Steck SE, Arab L, Zhang H, Bensen JT, Fontham ETH, Johnson CS, Mohler JL, Smith GJ, Su LJ, Woloszynska A.

Prostate. 2019 Jul;79(10):1117-1124. doi: 10.1002/pros.23824. Epub 2019 May 11.

4.

Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry.

Matejcic M, Saunders EJ, Dadaev T, Brook MN, Wang K, Sheng X, Olama AAA, Schumacher FR, Ingles SA, Govindasami K, Benlloch S, Berndt SI, Albanes D, Koutros S, Muir K, Stevens VL, Gapstur SM, Tangen CM, Batra J, Clements J, Gronberg H, Pashayan N, Schleutker J, Wolk A, West C, Mucci L, Kraft P, Cancel-Tassin G, Sorensen KD, Maehle L, Grindedal EM, Strom SS, Neal DE, Hamdy FC, Donovan JL, Travis RC, Hamilton RJ, Rosenstein B, Lu YJ, Giles GG, Kibel AS, Vega A, Bensen JT, Kogevinas M, Penney KL, Park JY, Stanford JL, Cybulski C, Nordestgaard BG, Brenner H, Maier C, Kim J, Teixeira MR, Neuhausen SL, De Ruyck K, Razack A, Newcomb LF, Lessel D, Kaneva R, Usmani N, Claessens F, Townsend PA, Gago-Dominguez M, Roobol MJ, Menegaux F, Khaw KT, Cannon-Albright LA, Pandha H, Thibodeau SN, Schaid DJ; PRACTICAL Consortium, Wiklund F, Chanock SJ, Easton DF, Eeles RA, Kote-Jarai Z, Conti DV, Haiman CA.

Nat Commun. 2019 Jan 17;10(1):382. doi: 10.1038/s41467-019-08293-z.

5.

Tea consumption and oxidative stress: a cross-sectional analysis of 889 premenopausal women from the Sister Study.

Zhang D, Ferguson K, Troester M, Bensen JT, Cai J, Milne GL, Sandler DP, Nichols HB.

Br J Nutr. 2018 Dec 20:1-23. doi: 10.1017/S0007114518003732. [Epub ahead of print] No abstract available.

PMID:
30567620
6.

Frailty and health-related quality of life in older women with breast cancer.

Williams GR, Deal AM, Sanoff HK, Nyrop KA, Guerard EJ, Pergolotti M, Shachar SS, Reeve BB, Bensen JT, Choi SK, Muss HB.

Support Care Cancer. 2019 Jul;27(7):2693-2698. doi: 10.1007/s00520-018-4558-6. Epub 2018 Nov 27.

PMID:
30484012
7.

Germline variation at 8q24 and prostate cancer risk in men of European ancestry.

Matejcic M, Saunders EJ, Dadaev T, Brook MN, Wang K, Sheng X, Olama AAA, Schumacher FR, Ingles SA, Govindasami K, Benlloch S, Berndt SI, Albanes D, Koutros S, Muir K, Stevens VL, Gapstur SM, Tangen CM, Batra J, Clements J, Gronberg H, Pashayan N, Schleutker J, Wolk A, West C, Mucci L, Kraft P, Cancel-Tassin G, Sorensen KD, Maehle L, Grindedal EM, Strom SS, Neal DE, Hamdy FC, Donovan JL, Travis RC, Hamilton RJ, Rosenstein B, Lu YJ, Giles GG, Kibel AS, Vega A, Bensen JT, Kogevinas M, Penney KL, Park JY, Stanford JL, Cybulski C, Nordestgaard BG, Brenner H, Maier C, Kim J, Teixeira MR, Neuhausen SL, De Ruyck K, Razack A, Newcomb LF, Lessel D, Kaneva R, Usmani N, Claessens F, Townsend PA, Gago-Dominguez M, Roobol MJ, Menegaux F, Khaw KT, Cannon-Albright LA, Pandha H, Thibodeau SN, Schaid DJ; PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Wiklund F, Chanock SJ, Easton DF, Eeles RA, Kote-Jarai Z, Conti DV, Haiman CA.

Nat Commun. 2018 Nov 5;9(1):4616. doi: 10.1038/s41467-018-06863-1. Erratum in: Nat Commun. 2019 Jan 17;10(1):382.

8.

Financial Toxicity in Adults With Cancer: Adverse Outcomes and Noncompliance.

Knight TG, Deal AM, Dusetzina SB, Muss HB, Choi SK, Bensen JT, Williams GR.

J Oncol Pract. 2018 Oct 24:JOP1800120. doi: 10.1200/JOP.18.00120. [Epub ahead of print]

PMID:
30355027
9.

Mononuclear phagocyte system function and nanoparticle pharmacology in obese and normal weight ovarian and endometrial cancer patients.

Starling BR, Kumar P, Lucas AT, Barrow D, Farnan L, Hendrix L, Giovinazzo H, Song G, Gehrig P, Bensen JT, Zamboni WC.

Cancer Chemother Pharmacol. 2019 Jan;83(1):61-70. doi: 10.1007/s00280-018-3702-9. Epub 2018 Oct 16.

PMID:
30327876
10.

Dietary patterns based on the Mediterranean diet and DASH diet are inversely associated with high aggressive prostate cancer in PCaP.

Schneider L, Su LJ, Arab L, Bensen JT, Farnan L, Fontham ETH, Song L, Hussey J, Merchant AT, Mohler JL, Steck SE.

Ann Epidemiol. 2019 Jan;29:16-22.e1. doi: 10.1016/j.annepidem.2018.08.012. Epub 2018 Sep 5.

PMID:
30268488
11.

The association of metformin use with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study.

Khan S, Cai J, Nielsen ME, Troester MA, Mohler JL, Fontham ETH, Farnan L, Drake BF, Olshan AF, Bensen JT.

Cancer Causes Control. 2018 Nov;29(11):1143-1150. doi: 10.1007/s10552-018-1087-z. Epub 2018 Sep 28.

12.

The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations.

Amendola LM, Berg JS, Horowitz CR, Angelo F, Bensen JT, Biesecker BB, Biesecker LG, Cooper GM, East K, Filipski K, Fullerton SM, Gelb BD, Goddard KAB, Hailu B, Hart R, Hassmiller-Lich K, Joseph G, Kenny EE, Koenig BA, Knight S, Kwok PY, Lewis KL, McGuire AL, Norton ME, Ou J, Parsons DW, Powell BC, Risch N, Robinson M, Rini C, Scollon S, Slavotinek AM, Veenstra DL, Wasserstein MP, Wilfond BS, Hindorff LA; CSER consortium, Plon SE, Jarvik GP.

Am J Hum Genet. 2018 Sep 6;103(3):319-327. doi: 10.1016/j.ajhg.2018.08.007.

13.

Modelling attrition and nonparticipation in a longitudinal study of prostate cancer.

Spiers S, Oral E, Fontham ETH, Peters ES, Mohler JL, Bensen JT, Brennan CS.

BMC Med Res Methodol. 2018 Jun 20;18(1):60. doi: 10.1186/s12874-018-0518-6.

14.

A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women.

Bensen JT, Graff M, Young KL, Sethupathy P, Parker J, Pecot CV, Currin K, Haddad SA, Ruiz-Narváez EA, Haiman CA, Hong CC, Sucheston-Campbell LE, Zhu Q, Liu S, Yao S, Bandera EV, Rosenberg L, Lunetta KL, Ambrosone CB, Palmer JR, Troester MA, Olshan AF.

Breast Cancer Res. 2018 Jun 5;20(1):45. doi: 10.1186/s13058-018-0964-4.

15.

Calcium, magnesium, and whole-milk intakes and high-aggressive prostate cancer in the North Carolina-Louisiana Prostate Cancer Project (PCaP).

Steck SE, Omofuma OO, Su LJ, Maise AA, Woloszynska-Read A, Johnson CS, Zhang H, Bensen JT, Fontham ETH, Mohler JL, Arab L.

Am J Clin Nutr. 2018 May 1;107(5):799-807. doi: 10.1093/ajcn/nqy037.

PMID:
29722851
16.

Statin use, high cholesterol and prostate cancer progression; results from HCaP-NC.

Allott EH, Farnan L, Steck SE, Song L, Arab L, Su LJ, Fontham ETH, Mohler JL, Bensen JT.

Prostate. 2018 Aug;78(11):857-864. doi: 10.1002/pros.23644. Epub 2018 May 1.

PMID:
29717502
17.

Frailty and Comorbidities Among Survivors of Adolescent and Young Adult Cancer: A Cross-Sectional Examination of a Hospital-Based Survivorship Cohort.

Smitherman AB, Anderson C, Lund JL, Bensen JT, Rosenstein DL, Nichols HB.

J Adolesc Young Adult Oncol. 2018 Jun;7(3):374-383. doi: 10.1089/jayao.2017.0103. Epub 2018 Mar 23.

18.

Social Relationships, Inflammation, and Cancer Survival.

Boen CE, Barrow DA, Bensen JT, Farnan L, Gerstel A, Hendrix LH, Yang YC.

Cancer Epidemiol Biomarkers Prev. 2018 May;27(5):541-549. doi: 10.1158/1055-9965.EPI-17-0836. Epub 2018 Feb 23.

19.

Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium.

Hong CC, Sucheston-Campbell LE, Liu S, Hu Q, Yao S, Lunetta KL, Haddad SA, Ruiz-Narváez EA, Bensen JT, Cheng TD, Bandera EV, Rosenberg LA, Haiman CA, Lee K, Evans SS, Abrams SI, Repasky EA, Olshan AF, Palmer JR, Ambrosone CB.

Cancer Epidemiol Biomarkers Prev. 2018 Mar;27(3):321-330. doi: 10.1158/1055-9965.EPI-17-0434. Epub 2018 Jan 16.

20.

Financial Toxicity among Patients with Bladder Cancer: Reasons for Delay in Care and Effect on Quality of Life.

Casilla-Lennon MM, Choi SK, Deal AM, Bensen JT, Narang G, Filippou P, McCormick B, Pruthi R, Wallen E, Tan HJ, Woods M, Nielsen M, Smith A.

J Urol. 2018 May;199(5):1166-1173. doi: 10.1016/j.juro.2017.10.049. Epub 2017 Nov 16.

21.

Prediagnostic Smoking Is Associated with Binary and Quantitative Measures of ER Protein and ESR1 mRNA Expression in Breast Tumors.

Butler EN, Bensen JT, Chen M, Conway K, Richardson DB, Sun X, Geradts J, Olshan AF, Troester MA.

Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):67-74. doi: 10.1158/1055-9965.EPI-17-0404. Epub 2017 Nov 13.

22.

Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry.

Conti DV, Wang K, Sheng X, Bensen JT, Hazelett DJ, Cook MB, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Stanford JL, Zheng W, Sanderson M, John EM, Park JY, Xu J, Stevens VL, Berndt SI, Huff CD, Wang Z, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Sellers TA, Yamoah K, Murphy AB, Crawford DC, Gapstur SM, Bush WS, Aldrich MC, Cussenot O, Petrovics G, Cullen J, Neslund-Dudas C, Stern MC, Jarai ZK, Govindasami K, Chokkalingam AP, Hsing AW, Goodman PJ, Hoffmann T, Drake BF, Hu JJ, Clark PE, Van Den Eeden SK, Blanchet P, Fowke JH, Casey G, Hennis AJM, Han Y, Lubwama A, Thompson IM Jr, Leach R, Easton DF, Schumacher F, Van den Berg DJ, Gundell SM, Stram A, Wan P, Xia L, Pooler LC, Mohler JL, Fontham ETH, Smith GJ, Taylor JA, Srivastava S, Eeles RA, Carpten J, Kibel AS, Multigner L, Parent ME, Menegaux F, Cancel-Tassin G, Klein EA, Brureau L, Stram DO, Watya S, Chanock SJ, Witte JS, Blot WJ, Henderson BE, Haiman CA; PRACTICAL/ELLIPSE Consortium.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djx084.

23.

Sexual Health Before Treatment in Women with Suspected Gynecologic Malignancy.

Bretschneider CE, Doll KM, Bensen JT, Gehrig PA, Wu JM, Geller EJ.

J Womens Health (Larchmt). 2017 Dec;26(12):1326-1332. doi: 10.1089/jwh.2016.6307. Epub 2017 Aug 22.

24.

Perioperative sexual interest in women with suspected gynecologic malignancies.

Bretschneider CE, Bensen JT, Geller EJ, Gehrig PA, Wu JM, Doll KM.

Gynecol Oncol. 2017 Jul;146(1):109-113. doi: 10.1016/j.ygyno.2017.04.001. Epub 2017 Apr 12.

PMID:
28410756
25.

Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry.

Feng Y, Rhie SK, Huo D, Ruiz-Narvaez EA, Haddad SA, Ambrosone CB, John EM, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, Deming SL, Rodriguez-Gil JL, Zheng Y, Yao S, Han YJ, Ogundiran TO, Rebbeck TR, Adebamowo C, Ojengbede O, Falusi AG, Hennis A, Nemesure B, Ambs S, Blot W, Cai Q, Signorello L, Nathanson KL, Lunetta KL, Sucheston-Campbell LE, Bensen JT, Chanock SJ, Marchand LL, Olshan AF, Kolonel LN, Conti DV, Coetzee GA, Stram DO, Olopade OI, Palmer JR, Haiman CA.

Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1016-1026. doi: 10.1158/1055-9965.EPI-16-0567. Epub 2017 Apr 4.

26.

Activities, function, and health-related quality of life (HRQOL) of older adults with cancer.

Pergolotti M, Deal AM, Williams GR, Bryant AL, Bensen JT, Muss HB, Reeve BB.

J Geriatr Oncol. 2017 Jul;8(4):249-254. doi: 10.1016/j.jgo.2017.02.009. Epub 2017 Mar 9.

27.

The Association of Diabetes and Obesity With Prostate Cancer Progression: HCaP-NC.

Khan S, Cai J, Nielsen ME, Troester MA, Mohler JL, Fontham ETH, Hendrix LH, Farnan L, Olshan AF, Bensen JT.

Prostate. 2017 Jun;77(8):878-887. doi: 10.1002/pros.23342. Epub 2017 Mar 6.

28.

Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer.

Huo D, Feng Y, Haddad S, Zheng Y, Yao S, Han YJ, Ogundiran TO, Adebamowo C, Ojengbede O, Falusi AG, Zheng W, Blot W, Cai Q, Signorello L, John EM, Bernstein L, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, Deming SL, Rodriguez-Gil JL, Nathanson KL, Domchek SM, Rebbeck TR, Ruiz-Narváez EA, Sucheston-Campbell LE, Bensen JT, Simon MS, Hennis A, Nemesure B, Leske MC, Ambs S, Chen LS, Qian F, Gamazon ER, Lunetta KL, Cox NJ, Chanock SJ, Kolonel LN, Olshan AF, Ambrosone CB, Olopade OI, Palmer JR, Haiman CA.

Hum Mol Genet. 2016 Nov 1;25(21):4835-4846. doi: 10.1093/hmg/ddw305.

29.

Unit Nonresponse in a Population-Based Study of Prostate Cancer.

Oral E, Simonsen N, Brennan C, Berken J, Su LJ, Mohler JL, Bensen JT, Fontham ET.

PLoS One. 2016 Dec 16;11(12):e0168364. doi: 10.1371/journal.pone.0168364. eCollection 2016.

30.

Genetic variation in the insulin, insulin-like growth factor, growth hormone, and leptin pathways in relation to breast cancer in African-American women: the AMBER consortium.

Ruiz-Narváez EA, Lunetta KL, Hong CC, Haddad S, Yao S, Cheng TD, Bensen JT, Bandera EV, Haiman CA, Troester MA, Ambrosone CB, Rosenberg L, Palmer JR.

NPJ Breast Cancer. 2016;2. pii: 16034. Epub 2016 Oct 26.

31.

The association of diabetes and obesity with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study.

Khan S, Cai J, Nielsen ME, Troester MA, Mohler JL, Fontham ET, Hendrix LH, Farnan L, Olshan AF, Bensen JT.

Cancer Causes Control. 2016 Dec;27(12):1475-1485. Epub 2016 Nov 9.

32.

Trans-ethnic follow-up of breast cancer GWAS hits using the preferential linkage disequilibrium approach.

Zhu Q, Shepherd L, Lunetta KL, Yao S, Liu Q, Hu Q, Haddad SA, Sucheston-Campbell L, Bensen JT, Bandera EV, Rosenberg L, Liu S, Haiman CA, Olshan AF, Palmer JR, Ambrosone CB.

Oncotarget. 2016 Dec 13;7(50):83160-83176. doi: 10.18632/oncotarget.13075.

33.

Admixture Mapping of African-American Women in the AMBER Consortium Identifies New Loci for Breast Cancer and Estrogen-Receptor Subtypes.

Ruiz-Narváez EA, Sucheston-Campbell L, Bensen JT, Yao S, Haddad S, Haiman CA, Bandera EV, John EM, Bernstein L, Hu JJ, Ziegler RG, Deming SL, Olshan AF, Ambrosone CB, Palmer JR, Lunetta KL.

Front Genet. 2016 Sep 21;7:170. eCollection 2016.

34.

Endocrine therapy and urogenital outcomes among women with a breast cancer diagnosis.

Landi SN, Doll KM, Bensen JT, Hendrix L, Anders CK, Wu JM, Nichols HB.

Cancer Causes Control. 2016 Nov;27(11):1325-1332. Epub 2016 Sep 28.

35.

Quality of care received and patient-reported regret in prostate cancer: Analysis of a population-based prospective cohort.

Holmes JA, Bensen JT, Mohler JL, Song L, Mishel MH, Chen RC.

Cancer. 2017 Jan 1;123(1):138-143. doi: 10.1002/cncr.30315. Epub 2016 Sep 13.

36.

Saturated fat intake and prostate cancer aggressiveness: results from the population-based North Carolina-Louisiana Prostate Cancer Project.

Allott EH, Arab L, Su LJ, Farnan L, Fontham ET, Mohler JL, Bensen JT, Steck SE.

Prostate Cancer Prostatic Dis. 2017 Mar;20(1):48-54. doi: 10.1038/pcan.2016.39. Epub 2016 Sep 6.

PMID:
27595916
37.

Genetic variations in the Hippo signaling pathway and breast cancer risk in African American women in the AMBER Consortium.

Zhang J, Yao S, Hu Q, Zhu Q, Liu S, Lunetta KL, Haddad SA, Yang N, Shen H, Hong CC, Sucheston-Campbell L, Ruiz-Narvaez EA, Bensen JT, Troester MA, Bandera EV, Rosenberg L, Haiman CA, Olshan AF, Palmer JR, Ambrosone CB.

Carcinogenesis. 2016 Oct;37(10):951-956. doi: 10.1093/carcin/bgw077. Epub 2016 Aug 1.

38.

Who presents satisfied? Non-modifiable factors associated with patient satisfaction among gynecologic oncology clinic patients.

Barber EL, Bensen JT, Snavely AC, Gehrig PA, Doll KM.

Gynecol Oncol. 2016 Aug;142(2):299-303. doi: 10.1016/j.ygyno.2016.06.009. Epub 2016 Jun 11.

39.

Carotenoid intake and adipose tissue carotenoid levels in relation to prostate cancer aggressiveness among African-American and European-American men in the North Carolina-Louisiana prostate cancer project (PCaP).

Antwi SO, Steck SE, Su LJ, Hebert JR, Zhang H, Craft NE, Fontham ET, Smith GJ, Bensen JT, Mohler JL, Arab L.

Prostate. 2016 Sep;76(12):1053-66. doi: 10.1002/pros.23189. Epub 2016 Jun 8.

40.

An exome-wide analysis of low frequency and rare variants in relation to risk of breast cancer in African American Women: the AMBER Consortium.

Haddad SA, Ruiz-Narváez EA, Haiman CA, Sucheston-Campbell LE, Bensen JT, Zhu Q, Liu S, Yao S, Bandera EV, Rosenberg L, Olshan AF, Ambrosone CB, Palmer JR, Lunetta KL.

Carcinogenesis. 2016 Sep;37(9):870-877. doi: 10.1093/carcin/bgw067. Epub 2016 Jun 7.

41.

The impact of surgical complications on health-related quality of life in women undergoing gynecologic and gynecologic oncology procedures: a prospective longitudinal cohort study.

Doll KM, Barber EL, Bensen JT, Revilla MC, Snavely AC, Bennett AV, Reeve BB, Gehrig PA.

Am J Obstet Gynecol. 2016 Oct;215(4):457.e1-457.e13. doi: 10.1016/j.ajog.2016.04.025. Epub 2016 Apr 27.

42.

The health-related quality of life journey of gynecologic oncology surgical patients: Implications for the incorporation of patient-reported outcomes into surgical quality metrics.

Doll KM, Barber EL, Bensen JT, Snavely AC, Gehrig PA.

Gynecol Oncol. 2016 May;141(2):329-335. doi: 10.1016/j.ygyno.2016.03.003. Epub 2016 Mar 18.

43.

Prevalence of pelvic floor disorders in women with suspected gynecological malignancy: a survey-based study.

Bretschneider CE, Doll KM, Bensen JT, Gehrig PA, Wu JM, Geller EJ.

Int Urogynecol J. 2016 Sep;27(9):1409-14. doi: 10.1007/s00192-016-2962-3. Epub 2016 Feb 12.

44.

Dietary Total Antioxidant Capacity is Inversely Associated with Prostate Cancer Aggressiveness in a Population-Based Study.

Vance TM, Wang Y, Su LJ, Fontham ET, Steck SE, Arab L, Bensen JT, Mohler JL, Chen MH, Chun OK.

Nutr Cancer. 2016;68(2):214-24. doi: 10.1080/01635581.2016.1134596. Epub 2016 Feb 4.

45.

Statin Use and Prostate Cancer Aggressiveness: Results from the Population-Based North Carolina-Louisiana Prostate Cancer Project.

Allott EH, Farnan L, Steck SE, Arab L, Su LJ, Mishel M, Fontham ET, Mohler JL, Bensen JT.

Cancer Epidemiol Biomarkers Prev. 2016 Apr;25(4):670-7. doi: 10.1158/1055-9965.EPI-15-0631. Epub 2016 Jan 27.

46.

Gene-based analysis of the fibroblast growth factor receptor signaling pathway in relation to breast cancer in African American women: the AMBER consortium.

Ruiz-Narváez EA, Haddad SA, Lunetta KL, Yao S, Bensen JT, Sucheston-Campbell LE, Hong CC, Haiman CA, Olshan AF, Ambrosone CB, Palmer JR.

Breast Cancer Res Treat. 2016 Jan;155(2):355-63. doi: 10.1007/s10549-015-3672-0. Epub 2016 Jan 7.

47.

Genetic variations in vitamin D-related pathways and breast cancer risk in African American women in the AMBER consortium.

Yao S, Haddad SA, Hu Q, Liu S, Lunetta KL, Ruiz-Narvaez EA, Hong CC, Zhu Q, Sucheston-Campbell L, Cheng TY, Bensen JT, Johnson CS, Trump DL, Haiman CA, Olshan AF, Palmer JR, Ambrosone CB.

Int J Cancer. 2016 May 1;138(9):2118-26. doi: 10.1002/ijc.29954. Epub 2015 Dec 28.

48.

Genetic variants in the mTOR pathway and breast cancer risk in African American women.

Cheng TD, Ambrosone CB, Hong CC, Lunetta KL, Liu S, Hu Q, Yao S, Sucheston-Campbell L, Bandera EV, Ruiz-Narváez EA, Haddad S, Troester MA, Haiman CA, Bensen JT, Olshan AF, Palmer JR, Rosenberg L.

Carcinogenesis. 2016 Jan;37(1):49-55. doi: 10.1093/carcin/bgv160. Epub 2015 Nov 16.

49.

Intake of dietary antioxidants is inversely associated with biomarkers of oxidative stress among men with prostate cancer.

Vance TM, Azabdaftari G, Pop EA, Lee SG, Su LJ, Fontham ET, Bensen JT, Steck SE, Arab L, Mohler JL, Chen MH, Koo SI, Chun OK.

Br J Nutr. 2016 Jan 14;115(1):68-74. doi: 10.1017/S0007114515004249. Epub 2015 Nov 2.

PMID:
26521663
50.

Hormone-related pathways and risk of breast cancer subtypes in African American women.

Haddad SA, Lunetta KL, Ruiz-Narváez EA, Bensen JT, Hong CC, Sucheston-Campbell LE, Yao S, Bandera EV, Rosenberg L, Haiman CA, Troester MA, Ambrosone CB, Palmer JR.

Breast Cancer Res Treat. 2015 Nov;154(1):145-54. doi: 10.1007/s10549-015-3594-x. Epub 2015 Oct 12.

Supplemental Content

Loading ...
Support Center